Actinogen Medical (ASX:ACW) Debt-to-Asset : 0.00 (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Actinogen Medical Debt-to-Asset?

Actinogen Medical's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.05 Mil. Actinogen Medical's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.00 Mil. Actinogen Medical's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was A$14.16 Mil. Actinogen Medical's debt to asset for the quarter that ended in Dec. 2023 was 0.00.

Actinogen Medical Debt-to-Asset Historical Data

The historical data trend for Actinogen Medical's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Actinogen Medical Debt-to-Asset Chart

Actinogen Medical Annual Data

Trend

Jun13

Jun14

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Debt-to-Asset

Get a 7-Day Free Trial

0.03

0.01

Actinogen Medical Semi-Annual Data
	Dec13	Jun14	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Asset	Get a 7-Day Free Trial															0.01	0.01	0.01	0.01	-

Competitive Comparison of Actinogen Medical's Debt-to-Asset

For the Biotechnology subindustry, Actinogen Medical's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Actinogen Medical's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Actinogen Medical's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Actinogen Medical's Debt-to-Asset falls into.

Actinogen Medical Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Actinogen Medical's Debt-to-Asset for the fiscal year that ended in Jun. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.087	+	0)	/	15.209
	=	0.01

Actinogen Medical's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.045	+	0)	/	14.164
	=	0.00

Actinogen Medical (ASX:ACW) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Actinogen Medical Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Actinogen Medical's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Actinogen Medical (ASX:ACW) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Actinogen Medical Ltd (ASX:ACW) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

3AC:Germany

Address

109 Pitt Street, Level 9, Suite 901, Sydney, NSW, AUS, 2000

Website

https://www.actinogen.com.au

Actinogen Medical Ltd is a biotechnology company. The company develops drugs for Alzheimer's disease and the cognitive decline associated with other neurological diseases. Geographically, it operates and derives revenue from Australia. It has developed a product Xanamem.

Actinogen Medical (ASX:ACW) Headlines

From GuruFocus

Accuride Corporation: Earnings Report For Q2 2014

By Black Iguana Nitish • 10-13-2014

Stocks That Are Making A Good Come Back

By reports.droy reports.droy • 03-10-2015